271 related articles for article (PubMed ID: 31578305)
21. Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model.
Leung J; St-Onge P; Stagg J; Suh WK
Cancer Immunol Immunother; 2017 Apr; 66(4):491-502. PubMed ID: 28074226
[TBL] [Abstract][Full Text] [Related]
22. Mannan-Binding Lectin Promotes Murine Graft-versus-Host Disease by Amplifying Lipopolysaccharide-Initiated Inflammation.
Heja D; Zhao D; Cody E; Cumpelik A; Lim PC; Prado-Acosta M; Palma L; Dellepiane S; Chun N; Ferrara J; Heeger PS
Transplant Cell Ther; 2022 Aug; 28(8):472.e1-472.e11. PubMed ID: 35643350
[TBL] [Abstract][Full Text] [Related]
23. Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.
Sang W; Zhou C; Cheng N; Li Z; Zeng L; Xu K
Immunol Lett; 2011 May; 136(2):194-202. PubMed ID: 21277900
[TBL] [Abstract][Full Text] [Related]
24. Local expression of B7-H4 by recombinant adenovirus transduction in mouse islets prolongs allograft survival.
Wang X; Hao J; Metzger DL; Mui A; Ao Z; Verchere CB; Chen L; Ou D; Warnock GL
Transplantation; 2009 Feb; 87(4):482-90. PubMed ID: 19307783
[TBL] [Abstract][Full Text] [Related]
25. Flt3 ligand (FL) treatment of murine donors does not modify graft-versus-host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality.
Blazar BR; McKenna HJ; Panoskaltsis-Mortari A; Taylor PA
Biol Blood Marrow Transplant; 2001; 7(4):197-207. PubMed ID: 11349806
[TBL] [Abstract][Full Text] [Related]
26. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
Radhakrishnan SV; Palaniyandi S; Mueller G; Miklos S; Hager M; Spacenko E; Karlsson FJ; Huber E; Kittan NA; Hildebrandt GC
Biol Blood Marrow Transplant; 2015 Jan; 21(1):30-8. PubMed ID: 25445642
[TBL] [Abstract][Full Text] [Related]
27. Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.
Blazar BR; Sharpe AH; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Korngold R; Vallera DA
J Immunol; 1996 Oct; 157(8):3250-9. PubMed ID: 8871619
[TBL] [Abstract][Full Text] [Related]
28. B7-H4, a promising target for immunotherapy.
Wang JY; Wang WP
Cell Immunol; 2020 Jan; 347():104008. PubMed ID: 31733822
[TBL] [Abstract][Full Text] [Related]
29. Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients.
Marks L; Altman NH; Podack ER; Levy RB
Transplantation; 2004 Mar; 77(6):804-12. PubMed ID: 15077018
[TBL] [Abstract][Full Text] [Related]
30. Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.
Yang YG; Dey BR; Sergio JJ; Pearson DA; Sykes M
J Clin Invest; 1998 Dec; 102(12):2126-35. PubMed ID: 9854048
[TBL] [Abstract][Full Text] [Related]
31. The B7-H4 gene induces immune escape partly via upregulating the PD-1/Stat3 pathway in non-small cell lung cancer.
Yuan L; Ye J; Fan D
Hum Immunol; 2020 May; 81(5):254-261. PubMed ID: 32113654
[TBL] [Abstract][Full Text] [Related]
32. Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses.
Vogtenhuber C; Bucher C; Highfill SL; Koch LK; Goren E; Panoskaltsis-Mortari A; Taylor PA; Farrar MA; Blazar BR
Blood; 2010 Jul; 116(3):466-74. PubMed ID: 20442366
[TBL] [Abstract][Full Text] [Related]
33. The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity.
Xue Q; Luan XY; Gu YZ; Wu HY; Zhang GB; Yu GH; Zhu HT; Wang M; Dong W; Geng YJ; Zhang XG
Stem Cells Dev; 2010 Jan; 19(1):27-38. PubMed ID: 19788399
[TBL] [Abstract][Full Text] [Related]
34. Host-Derived CD70 Suppresses Murine Graft-versus-Host Disease by Limiting Donor T Cell Expansion and Effector Function.
Leigh ND; O'Neill RE; Du W; Chen C; Qiu J; Ashwell JD; McCarthy PL; Chen GL; Cao X
J Immunol; 2017 Jul; 199(1):336-347. PubMed ID: 28550198
[TBL] [Abstract][Full Text] [Related]
35. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
36. Blockade of both B7-H4 and CTLA-4 co-signaling pathways enhances mouse islet allograft survival.
Wang X; Hao J; Metzger DL; Mui A; Lee IF; Akhoundsadegh N; Chen CL; Ou D; Ao Z; Verchere CB; Warnock GL
Islets; 2012; 4(4):284-95. PubMed ID: 22878670
[TBL] [Abstract][Full Text] [Related]
37. Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.
Giver CR; Montes RO; Mittelstaedt S; Li JM; Jaye DL; Lonial S; Boyer MW; Waller EK
Biol Blood Marrow Transplant; 2003 Oct; 9(10):616-32. PubMed ID: 14569558
[TBL] [Abstract][Full Text] [Related]
38. CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells.
Blazar BR; Taylor PA; Boyer MW; Panoskaltsis-Mortari A; Allison JP; Vallera DA
J Immunol; 1997 Oct; 159(7):3460-73. PubMed ID: 9317145
[TBL] [Abstract][Full Text] [Related]
39. Differential Effects of Gut-Homing Molecules CC Chemokine Receptor 9 and Integrin-β7 during Acute Graft-versus-Host Disease of the Liver.
Schreder A; Moschovakis GL; Halle S; Schlue J; Lee CW; Schippers A; David S; Bernhardt G; Ganser A; Pabst O; Förster R; Koenecke C
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2069-2078. PubMed ID: 26348893
[TBL] [Abstract][Full Text] [Related]
40. Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration.
Aoyama K; Saha A; Tolar J; Riddle MJ; Veenstra RG; Taylor PA; Blomhoff R; Panoskaltsis-Mortari A; Klebanoff CA; Socié G; Munn DH; Murphy WJ; Serody JS; Fulton LM; Teshima T; Chandraratna RA; Dmitrovsky E; Guo Y; Noelle RJ; Blazar BR
Blood; 2013 Sep; 122(12):2125-34. PubMed ID: 23814022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
